1
|
Helmick CG, Felson DT, Lawrence RC,
Gabriel S, Hirsch R, Kwoh CK, Liang MH, Kremers HM, Mayes MD,
Merkel PA, et al: Estimates of the prevalence of arthritis and
other rheumatic conditions in the United States. Part I. Arthritis
Rheum. 58:15–25. 2008. View Article : Google Scholar : PubMed/NCBI
|
2
|
Innala L, Sjöberg C, Möller B, Ljung L,
Smedby T, Södergren A, Magnusson S, Rantapää-Dahlqvist S and
Wållberg-Jonsson S: Co-morbidity in patients with early rheumatoid
arthritis-inflammation matters. Arthritis Res Ther. 18:332016.
View Article : Google Scholar : PubMed/NCBI
|
3
|
Shegarfi H, Naddafi F and Mirshafiey A:
Natural killer cells and their role in rheumatoid arthritis: Friend
or foe? ScientificWorld Journal. 2012.4919742012.PubMed/NCBI
|
4
|
MacNaul KL, Hutchinson NI, Parsons JN,
Bayne EK and Tocci MJ: Analysis of IL-1 and TNF-alpha gene
expression in human rheumatoid synoviocytes and normal monocytes by
in situ hybridization. J Immunol. 45:4154–4166. 1990.
|
5
|
Azizi G, Jadidi-Niaragh F and Mirshafiey
A: Th17 Cells in Immunopathogenesis and treatment of rheumatoid
arthritis. Int J Rheum Dis. 16:243–253. 2013. View Article : Google Scholar : PubMed/NCBI
|
6
|
Zhu J, Yamane H and Paul WE:
Differentiation of effector CD4 T cell populations (*). Annu Rev
Immunol. 28:445–489. 2010. View Article : Google Scholar : PubMed/NCBI
|
7
|
Harrington LE, Hatton RD, Mangan PR,
Turner H, Murphy TL, Murphy KM and Weaver CT: Interleukin
17-producing CD4+ effector T cells develop via a lineage distinct
from the T helper type 1 and 2 lineages. Nat Immunol. 6:1123–1132.
2005. View
Article : Google Scholar : PubMed/NCBI
|
8
|
Park H, Li Z, Yang XO, Chang SH, Nurieva
R, Wang YH, Wang Y, Hood L, Zhu Z, Tian Q and Dong C: A distinct
lineage of CD4 T cells regulates tissue inflammation by producing
interleukin 17. Nat Immunol. 6:1133–1141. 2005. View Article : Google Scholar : PubMed/NCBI
|
9
|
Firestein GS: Evolving concepts of
rheumatoid arthritis. Nature. 423:356–361. 2003. View Article : Google Scholar : PubMed/NCBI
|
10
|
Aarvak T, Chabaud M, Källberg E, Miossec P
and Natvig JB: Change in the Th1/Th2 phenotype of memory T-cell
clones from rheumatoid arthritis synovium. Scand J Immunol. 50:1–9.
1999. View Article : Google Scholar : PubMed/NCBI
|
11
|
Talaat RM, Mohamed SF, Bassyouni IH and
Raouf AA: Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus
erythematosus (SLE) patients: Correlation with disease activity.
Cytokine. 72:146–153. 2015. View Article : Google Scholar : PubMed/NCBI
|
12
|
Heo YJ, Joo YB, Oh HJ, Park MK, Heo YM,
Cho ML, Kwok SK, Ju JH, Park KS, Cho SG, et al: IL-10 suppresses
Th17 cells and promotes regulatory T cells in the CD4+ T cell
population of rheumatoid arthritis patients. Immunol Lett.
127:150–156. 2010. View Article : Google Scholar : PubMed/NCBI
|
13
|
Louten J, Boniface K and de Waal Malefyt
R: Development and function of TH17 cells in health and disease. J
Allergy Clin Immunol. 123:1004–1011. 2009. View Article : Google Scholar : PubMed/NCBI
|
14
|
Dejaco C, Duftner C, Klauser A and
Schirmer M: Altered T-cell subtypes in spondyloarthritis,
rheumatoid arthritis and polymyalgia rheumatica. Rheumatol Int.
30:297–303. 2010. View Article : Google Scholar : PubMed/NCBI
|
15
|
Komatsu N and Takayanagi H: Regulatory T
cells in Arthritis. Prog Mol Biol Transl Sci. 136:207–215. 2015.
View Article : Google Scholar : PubMed/NCBI
|
16
|
Gizinski AM and Fox DA: T cell subsets and
their role in the pathogenesis of rheumatic disease. Curr Opin
Rheumatol. 26:204–210. 2014. View Article : Google Scholar : PubMed/NCBI
|
17
|
Alunno A, Manetti M, Caterbi S,
Ibba-Manneschi L, Bistoni O, Bartoloni E, Valentini V, Terenzi R
and Gerli R: Altered Immunoregulation in Rheumatoid Arthritis: The
Role of Regulatory T Cells and Proinflammatory Th17 Cells and
Therapeutic Implications. Mediators Inflamm. 2015:7517932015.
View Article : Google Scholar : PubMed/NCBI
|
18
|
Nam JL, Winthrop KL, Van Vollenhoven RF,
Pavelka K, Valesini G, Hensor EM, Worthy G, Landewé R, Smolen JS,
Emery P and Buch MH: Current evidence for the management of
rheumatoid arthritis with biological disease-modifying
antirheumatic drugs: A systematic literature review informing the
EULAR recommendations for the management of RA. Ann Rheum Dis.
69:976–986. 2010. View Article : Google Scholar : PubMed/NCBI
|
19
|
Romas E, Gillespie MT and Martin TJ:
Involvement of receptor activator of NFkappaB ligand and tumor
necrosis factor-alpha in bone destruction in rheumatoid arthritis.
Bone. 30:340–346. 2002. View Article : Google Scholar : PubMed/NCBI
|
20
|
Chan FK: The David Y. Graham lecture: Use
of nonsteroidal antiinflammatory drugs in a COX-2 restricted
environment. Am J Gastroenterol. 103:221–227. 2008. View Article : Google Scholar : PubMed/NCBI
|
21
|
Mosleh W and Farkouh ME: Balancing
cardiovascular and gastrointestinal risks in patients with
osteoarthritis receiving nonsteroidal anti-inflammatory drugs. A
summary of guidelines from an international expert group. Pol Arch
Med Wewn. 126:68–75. 2016.PubMed/NCBI
|
22
|
Pope JE, Anderson JJ and Felson DT: A
meta-analysis of the effects of nonsteroidal anti-inflammatory
drugs on blood pressure. Arch Intern Med. 153:477–484. 1993.
View Article : Google Scholar : PubMed/NCBI
|
23
|
McGettigan P and Henry D: Cardiovascular
risk with non-steroidal anti-inflammatory drugs: Systematic review
of population-based controlled observational studies. PLoS Med.
8:e10010982011. View Article : Google Scholar : PubMed/NCBI
|
24
|
Harrold LR, Reed GW, Harrington JT, Barr
CJ, Saunders KC, Gibofsky A, Greenberg JD, John A, Devenport J and
Kremer JM: The rheumatoid arthritis treat-to-target trial: A
cluster randomized trial within the Corrona rheumatology network.
BMC Musculoskelet Disord. 15:3892014. View Article : Google Scholar : PubMed/NCBI
|
25
|
Smolen JS and Steiner G: Therapeutic
strategies for rheumatoid arthritis. Nat Rev Drug Discov.
2:473–488. 2003. View
Article : Google Scholar : PubMed/NCBI
|
26
|
Olsen NJ and Stein CM: New drugs for
rheumatoid arthritis. N Engl J Med. 350:2167–2179. 2004. View Article : Google Scholar : PubMed/NCBI
|
27
|
Lee JD, Huh JE, Baek YH, Cho KC, Choi DY
and Park DS: The Efficacy and Mechanism Action of RvCSd, a New
herbal agent, on immune suppression and cartilage protection in a
mouse model of rheumatoid arthritis. J Pharmacol Sci. 109:211–221.
2009. View Article : Google Scholar : PubMed/NCBI
|
28
|
Guzman JR, Koo JS, Goldsmith JR, Mühlbauer
M, Narula A and Jobin C: Oxymatrine prevents NF-κB nuclear
translocation and ameliorates acute intestinal inflammation. Sci
Rep. 3:16292013. View Article : Google Scholar : PubMed/NCBI
|
29
|
Dong XQ, Yu WH, Hu YY, Zhang ZY and Huang
M: Oxymatrine reduces neuronal cell apoptosis by inhibiting
Toll-like receptor 4/nuclear factor kappa-B-dependent inflammatory
responses in traumatic rat brain injury. Inflamm Res. 60:533–539.
2011. View Article : Google Scholar : PubMed/NCBI
|
30
|
Jiang G, Liu X, Wang M, Chen H, Chen Z and
Qiu T: Oxymatrine ameliorates renal ischemia-reperfusion injury
from oxidative stress through Nrf2/HO-1 pathway. Acta Cir Bras.
30:422–429. 2015. View Article : Google Scholar : PubMed/NCBI
|
31
|
Yao N and Wang X: In vitro
immunomodulatory activity of oxymatrine on Toll-like receptor 9
signal pathway in chronic hepatitis B. Am J Chin Med. 42:1399–1410.
2014. View Article : Google Scholar : PubMed/NCBI
|
32
|
Li J, Jiang K and Zhao F: Oxymatrine
suppresses proliferation and facilitates apoptosis of human ovarian
cancer cells through upregulating microRNA-29b and downregulating
matrix metalloproteinase-2 expression. Mol Med Rep. 12:5369–5374.
2015.PubMed/NCBI
|
33
|
Wang W, Pei X, Xu M, Sun S, Zhang C, Mu K
and Liu Z: The Protective Effect of Sodium Ferulate and Oxymatrine
Combination on Paraquat-induced Lung Injury. Iran J Pharm Res.
14:573–583. 2015.PubMed/NCBI
|
34
|
Wu C, Huang W, Guo Y, Xia P, Sun X, Pan X
and Hu W: Oxymatrine inhibits the proliferation of prostate cancer
cells in vitro and in vivo. Mol Med Rep. 11:4129–4134.
2015.PubMed/NCBI
|
35
|
Parvez MK, Arbab AH, Al-Dosari MS and
Al-Rehaily AJ: Antiviral natural products against chronic hepatitis
B: Recent Developments. Curr Pharm Des. 22:286–293. 2016.
View Article : Google Scholar : PubMed/NCBI
|
36
|
Mason TJ and Matthews M: Aquatic
environment, housing and management in the eighth edition of the
guide for the care and use of laboratory animals: Additional
considerations and recommendations. J Am Assoc Lab Anim Sci.
51:329–332. 2012.PubMed/NCBI
|
37
|
Pfaffl MW: A new mathematical model for
relative quantification in real-time RT-PCR. Nucleic Acids Res.
29:e452001. View Article : Google Scholar : PubMed/NCBI
|
38
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
39
|
Klarenbeek NB, Kerstens PJ, Huizinga TW,
Dijkmans BA and Allaart CF: Recent advances in the management of
rheumatoid arthritis. Br Med J. 341:c69422010. View Article : Google Scholar
|
40
|
Katsuragi T, Iwashige A and Tsukada J:
Immunodeficiency-associated Burkitt lymphoma developed in a patient
receiving a long-term methotrexate therapy for rheumatoid
arthritis. Rinsho Ketsueki. 57:9–14. 2016.(In Japanese). PubMed/NCBI
|
41
|
Scott FI, Mamtani R, Brensinger CM, Haynes
K, Chiesa-Fuxench ZC, Zhang J, Chen L, Xie F, Yun H, Osterman MT,
et al: Risk of nonmelanoma skin cancer associated with the use of
immunosuppressant and biologic agents in patients with a history of
autoimmune disease and nonmelanoma skin cancer. JAMA Dermatol.
152:164–172. 2016. View Article : Google Scholar : PubMed/NCBI
|
42
|
Wang X, Liu C, Wang J, Fan Y, Wang Z and
Wang Y: Oxymatrine inhibits the migration of human colorectal
carcinoma RKO cells via inhibition of PAI-1 and the TGF-β1/Smad
signaling pathway. Oncol Rep. 37:747–753. 2017.PubMed/NCBI
|
43
|
Estrada-Capetillo L, Hernández-Castro B,
Monsiváis-Urenda A, Alvarez-Quiroga C, Layseca-Espinosa E,
Abud-Mendoza C, Baranda L, Urzainqui A, Sánchez-Madrid F and
González-Amaro R: Induction of Th17 lymphocytes and Treg cells by
monocyte-derived dendritic cells in patients with rheumatoid
arthritis and systemic lupus erythematosus. Clin Dev Immunol.
2013:5843032013. View Article : Google Scholar : PubMed/NCBI
|
44
|
Bettelli E, Korn T and Kuchroo VK: Th17:
The third member of the effector T cell trlogy. Curr Opin Immunol.
19:652–657. 2007. View Article : Google Scholar : PubMed/NCBI
|
45
|
Weaver CT, Harrington LE, Mangan PR,
Gavrieli M and Murphy KM: Th17: An effector CD4 T cell lineage with
regulatory T Cell ties. Immunity. 24:677–688. 2006. View Article : Google Scholar : PubMed/NCBI
|
46
|
Komatsu N and Takayanagi H: Regulatory T
cells in Arthritis. Prog Mol Biol Transl Sci. 136:207–215. 2015.
View Article : Google Scholar : PubMed/NCBI
|
47
|
An Haack I, Derkow K, Riehn M, Rentinck
MN, Kühl AA, Lehnardt S and Schott E: The Role of Regulatory CD4 T
Cells in Maintaining Tolerance in a Mouse Model of autoimmune
hepatitis. PLoS One. 10:e01437152015. View Article : Google Scholar : PubMed/NCBI
|
48
|
Lina C, Conghua W, Nan L and Ping Z:
Combined treatment of etanercept and MTX reverses Th1/Th2,
Th17/Treg imbalance in patients with rheumatoid arthritis. J Clin
Immunol. 31:596–605. 2011. View Article : Google Scholar : PubMed/NCBI
|
49
|
Venkatesha SH, Dudics S, Weingartner E, So
EC, Pedra J and Moudgil KD: Altered Th17/Treg balance and
dysregulated IL-1β response influence susceptibility/resistance to
experimental autoimmune arthritis. Int J Immunopathol Pharmacol.
28:318–328. 2015. View Article : Google Scholar : PubMed/NCBI
|
50
|
Fischer A: Human immunodeficiency:
Connecting STAT3, Th17 and human mucosal immunity. Immunol Cell
Biol. 86:549–551. 2008. View Article : Google Scholar : PubMed/NCBI
|
51
|
Yang XP, Ghoreschi K, Steward-Tharp SM,
Rodriguez-Canales J, Zhu J, Grainger JR, Hirahara K, Sun HW, Wei L,
Vahedi G, et al: Opposing regulation of the locus encoding IL-17
through direct, reciprocal actions of STAT3 and STAT5. Nat Immunol.
12:247–254. 2011. View Article : Google Scholar : PubMed/NCBI
|